Clinical Trial Update: Clinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in Care

View source ↗

Summary

An ongoing hybrid effectiveness-implementation study is evaluating home-delivered Cabenuva for people living with HIV who are not retained in care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CABENUVA (cabotegravir and rilpivirine)

Snippet

Sponsor: Whitman-Walker Institute | Conditions: HIV | Status: ENROLLING_BY_INVITATION